tiprankstipranks
Blurbs

Analysts Offer Insights on Healthcare Companies: Option Care Health (OPCH), Teleflex (TFX) and Teladoc (TDOC)

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Option Care Health (OPCHResearch Report), Teleflex (TFXResearch Report) and Teladoc (TDOCResearch Report).

Option Care Health (OPCH)

Deutsche Bank analyst Pito Chickering reiterated a Buy rating on Option Care Health on July 27 and set a price target of $39.00. The company’s shares closed last Thursday at $33.93.

According to TipRanks.com, Chickering is a 2-star analyst with an average return of 0.9% and a 40.2% success rate. Chickering covers the Healthcare sector, focusing on stocks such as Aveanna Healthcare Holdings, Bausch + Lomb Corporation, and Zimmer Biomet Holdings.

The word on The Street in general, suggests a Strong Buy analyst consensus rating for Option Care Health with a $39.40 average price target, implying a 18.5% upside from current levels. In a report released yesterday, Lake Street also maintained a Buy rating on the stock with a $45.00 price target.

See the top stocks recommended by analysts >>

Teleflex (TFX)

In a report released today, David Turkaly from JMP Securities reiterated a Buy rating on Teleflex, with a price target of $370.00. The company’s shares closed last Thursday at $245.69, close to its 52-week low of $235.58.

According to TipRanks.com, Turkaly is a 4-star analyst with an average return of 4.5% and a 46.6% success rate. Turkaly covers the Healthcare sector, focusing on stocks such as Zimmer Biomet Holdings, Integra Lifesciences, and OrthoPediatrics.

Teleflex has an analyst consensus of Moderate Buy, with a price target consensus of $320.00.

Teladoc (TDOC)

BTIG analyst David Larsen maintained a Hold rating on Teladoc on July 27. The company’s shares closed last Thursday at $35.60, close to its 52-week low of $27.38.

According to TipRanks.com, Larsen has currently 0 stars on a ranking scale of 0-5 stars, with an average return of -8.5% and a 35.0% success rate. Larsen covers the Technology sector, focusing on stocks such as Health Catalyst, American Well, and Sharecare.

Currently, the analyst consensus on Teladoc is a Moderate Buy with an average price target of $40.07, implying a 13.6% upside from current levels. In a report released yesterday, Goldman Sachs also downgraded the stock to Hold with a $36.00 price target.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Read More on OPCH:

Tired of arriving late to the Big Returns Party?​
Most investors don’t have major gainers like TSLA or NVDA on their radar from the start.
The profusion of opinions on social media and financial blogs makes it impossible to distinguish between real growth potential and pure hype.
​​For the past decade, we have developed and perfected technology designed to help private investors, just like you, find the best opportunities, with the greatest upside potential, in any financial climate.​
Learn More